Olin OLN
NYSE · Chemicals & Allied Products · $1.9BData provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
2 stories have a settled next close so far (2 on the Wire). The record starts speaking at three.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via DatabentoOperating leverage — margins
| Line Item (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY Δ | 4Y CAGR | Trend |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | $8.9B | $9.4B | $6.8B | $6.5B | $6.8B | +3.7% | −6.6% | |
| Cost of Revenue (COGS) | $6.6B | $7.2B | $5.7B | $5.8B | $6.3B | +8.2% | −1.3% | |
| Gross Profit | — | $2.2B | $1.2B | $737.5M | $501.5M | −32.0% | −38.7% | |
| Selling, General & Admin (SG&A) | $416.9M | $393.9M | $406.7M | $408.5M | $463.3M | +13.4% | +2.7% | |
| Total Operating Expenses | — | $402.9M | $453.4M | $441.0M | $496.2M | +12.5% | +7.2% | |
| Operating Income (EBIT) | $1.9B | $1.8B | $712.1M | $296.5M | $5.3M | −98.2% | −76.9% | |
| Interest Expense | $348.0M | $143.9M | $181.1M | $184.5M | $188.3M | +2.1% | −14.2% | |
| Income Tax Expense | $242.0M | $349.1M | $107.3M | $36.7M | $-60.0M | −263.5% | — | |
| GAAP Net Income | $1.3B | $1.3B | $452.0M | $105.0M | $-101.1M | −196.3% | — | |
| Diluted EPS | $7.96 | $8.94 | $3.57 | $0.91 | $-0.88 | −196.7% | — | |
| Diluted Shares | 163.0M | 148.5M | 128.8M | 119.5M | 114.6M | −4.1% | −8.4% | |
| Balance Sheet | ||||||||
| Cash & Equivalents | $180.5M | $194.0M | $170.3M | $175.6M | $167.6M | −4.6% | −1.8% | |
| Inventory | $868.3M | $941.9M | $858.8M | $823.5M | $784.5M | −4.7% | −2.5% | |
| Total Current Assets | $2.2B | $2.2B | $2.0B | $2.1B | $2.0B | −5.2% | −3.2% | |
| Total Assets | $8.5B | $8.0B | $7.7B | $7.6B | $7.3B | −3.3% | −3.7% | |
| Total Current Liabilities | $1.7B | $1.6B | $1.5B | $1.6B | $1.6B | −0.2% | −0.8% | |
| Total Debt (Short + Long Term) | $2.8B | $2.6B | $2.7B | $2.8B | $2.8B | −0.5% | +0.4% | |
| Total Liabilities | $5.9B | $5.5B | $5.4B | $5.5B | $5.5B | −1.2% | −1.8% | |
| Stockholders' Equity | $2.7B | $2.5B | $2.3B | $2.1B | $1.9B | −9.0% | −8.4% | |
| Net Cash / (Net Debt) | $-2.6B | $-2.4B | $-2.5B | $-2.7B | $-2.7B | +0.3% | — | |
| Invested Capital | $5.3B | $4.9B | $4.8B | $4.7B | $4.5B | −4.1% | −3.6% | |
| Cash Flow & Capital Allocation | ||||||||
| Operating Cash Flow (OCF) | $1.7B | $1.9B | $974.3M | $503.2M | $474.2M | −5.8% | −27.8% | |
| Depreciation & Amortization (D&A) | $582.5M | $598.8M | $533.4M | $518.1M | $521.6M | +0.7% | −2.7% | |
| Stock-Based Compensation (SBC) | $8.3M | $14.1M | $18.6M | $17.1M | $20.7M | +21.1% | +25.7% | |
| Capital Expenditures (CapEx) | $200.6M | $236.9M | $236.0M | $195.1M | $226.3M | +16.0% | +3.1% | |
| Free Cash Flow (FCF) | $1.5B | $1.7B | $738.3M | $308.1M | $247.9M | −19.5% | −36.7% | |
| True FCF (ex-SBC Owner Cash) | $1.5B | $1.7B | $719.7M | $291.0M | $227.2M | −21.9% | −37.9% | |
| Share Repurchases (Buybacks) | $251.9M | $1.4B | $711.3M | $300.3M | $50.5M | −83.2% | −33.1% | |
| Dividends Paid | $127.8M | $116.2M | $101.0M | $94.2M | $91.6M | −2.8% | −8.0% | |
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.